Photodynamic therapy using photofrin in combination with buthionine sulfoximine (BSO) to treat 9L gliosarcoma in rat brain

Lasers in Surgery and Medicine

Volumn 23, Issue 3, 1998, Pages 161-166

  Jiang, Feng ^a   Lilge, Lothar ^b   Belcuig, Marie ^c   Singh, Gurmit ^c   Grenier, Joseph ^a,d   Li, Yi ^a   Chopp, Michael ^a,d,e  

^a HENRY FORD HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d OAKLAND UNIVERSITY   (United States)

^e HENRY FORD HOSPITAL   (United States)

Author keywords

Buthionine sulfoximine; Gliosarcoma; Glutathione; Photodynamic therapy; Photofrin; Rat

Indexed keywords

BUTHIONINE SULFOXIMINE; PHOTOFRIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TUMOR; CELL DAMAGE; CENTRAL NERVOUS SYSTEM TUMOR; CONTROLLED STUDY; GLIOSARCOMA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RAT; TUMOR NECROSIS;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN; BRAIN CHEMISTRY; BRAIN NEOPLASMS; BUTHIONINE SULFOXIMINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIHEMATOPORPHYRIN ETHER; FREE RADICALS; GLIOSARCOMA; GLUTATHIONE; MALE; NECROSIS; OXIDATION-REDUCTION; PHOTOCHEMOTHERAPY; RADIATION-SENSITIZING AGENTS; RATS; RATS, INBRED F344; REACTIVE OXYGEN SPECIES;

EID: 0031702818     PISSN: 01968092     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9101(1998)23:3<161::AID-LSM5>3.0.CO;2-N     Document Type: Article

References (28)

1. Schuster JM, Friedman HS, Archer GE, Fuchs HE, McLendon RE, Colvin OM, Bigner DD. Intraarterial therapy of human glioma xenografts in athymic rats using 4-hydroperoxycyclophosphamide. Cancer Res 1993; 53:2338-2343.
2. Walsh ARW, Darling JL, Thomas DGT. Cerebral gliomas. In Kennard C, ed. "Recent Advances in Clinical Neurology." Edinburgh: Churchill Livingstone, 1990, pp 241-268.
3. Mahaley SM, Mettlin C, Natarajan N, Laws ER, Peace BB. National survey of patterns of care for brain tumor patients. J Neurosurg 1989; 71:826-836.
4. Power SK, Cush SS, Walsted DL, Kwock L. Stereotactic intratumoral photodynamic therapy for recurrent malignant brain tumors. Neurosurgery 1991; 29:688-696.
5. Jiang F, Lilge L, Logie B, Li Y, Chopp M. Photodynamic therapy of 9L gliosarcoma with lipsome-delivered Photofrin. Photochem Photobiol 1997; 65:701-706.
6. Chopp M, Madigan L, Dereski M, Jiang F, Li Y. Photodynamic therapy of human glioma (U87) in the nude rat. Photochem Photobiol 1996; 64:707-711.
7. Griffith OW, Meister A. Glutathione: interorgan translocation turnover, and metabolism. Proc Natl Acad Sci USA 1979; 76:5606-5610.
8. Fekete I, Griffith OW, Schlageter KE, Bigner DD, Friedman HS, Groothuis DR. Rate of buthionine sulfoximine entry into brain and xenotransplanted human gliomas. Cancer Res 1990; 50:1251-1256.
9. Mitchell JB, Morstyn G, Russo A, Carney DN. In vivo radiobiology of human lung cancer. Cancer Treat Symp 1985; 2:3-10.
10. Biaglow JE, Clark EP, Epp ER, Morse-Gaudia M, Varnes ME, Mitchell JB. Nonprotein thiols and the radiation response of A549 human lung carcinoma cell. Int J Radiat Biol Relat Stud Phys Chem Med 1983; 44:489-495.
11. Ozols RF, Louie GK, Plowman J, Behrens BC, Fine RL, Dykes D, Hamilton TC. Enhanced melphalan toxicity in human ovarian cancer in vitro and in tumor-bearing nude mice by buthionine sulfoximine depletion of glutathione. Biochem Pharmacol 1987; 36:147-153.
12. Dethmers JK, Meister A. Glutathione export by human lymphoid cells: depletion of glutathione by inhibition of its synthesis decreases export and increases sensitivity to irradiation. Proc Natl Acad Sci USA 1981; 78:7492-7496.
13. Lee FYF, Siemann DW, Sutherland RM. Changes in cellular glutathione content during adriamycin treatment in human ovarian cancer: A possible indicator of chemosensitivity. Br J Cancer 1989; 60:291-298.
14. Mayer RD, Lee K, Cockett ATK. Inhibition of cisplatininduced nephrotoxicity in rats by buthionine sulfoximine: A glutathione synthesis inhibitor. Cancer Chemother Pharmacol 1987; 20:207-210.
15. Malaker K, Hurwitz SJ, Bump EA, Griffith OW, Lai LL, Riese N, Coleman CN. Pharmacodynamics of prolonged treatment with 1, S-buthionine sulfoximine. Int J Rad Oncol Biol Phys 1994; 29:407-412.
16. Meister A. Metabolism and transport of glutathione and other r-glutamyl compounds. In Larsson A, et al. "Functions of Glutathione: Biochemical, Physiological, Toxicological and Clinical Aspects." New York: Raven Press, 1983, pp 1-22.
17. Griffith OW. Mechanism of action, metabolism, and toxicity of buthionine sulfoximine and its higher homologs, potent inhibitors of glutathione synthesis. J Biol Chem 1982; 257:13704-13712.
18. Miller AC, Henderson BW. The influence of cellular glutathione content on cell survival following photodynamic treatment in vitro. Rad Res 1986; 107:83-94.
19. Chopp M, Dereski MO, Madigan L, Jiang F, Logie B. Sensitivity of 9L gliosarcomas to photodynamic therapy. Rad Res 1996; 146:461-465.
20. Lilge L, O'Carroll C, Wilson BC. A solubilization technique for photosensitizer quantification in ex vivo tissue samples. J Photochem Photobiol 1997 (in press).
21. Anderson ME. Determination of glutathione and glutathione disulfide in biological samples. Meth Enzymol 1985; 113:548-555.
22. Meister A. Glutathione deficiency produced by inhibition of its synthesis and its reversal; applications in research and therapy. Pharmacol Ther 1991; 51:155-194.
23. Kessel D, Kohn KI. Transport and binding of mesoporphyrin IX by leukemia L1210 cells. Cancer Res 1980; 40: 303-307.
24. Bellnier DA, Dougherty TJ. Membrane lysis in Chinese hamster ovary cells treated with hematoporphyrin derivative plus light. Photochem Photobiol 1982; 36:43-47.
25. Das M, Mukhtar H, Greenspan ER, Bickers DR. Photoenhancement of lipid peroxidation associated with the generation of reactive oxygen species in hepatic microsomes of hematoporphyrin-treated rats. Cancer Res 1985; 45:6328-6330.
26. Younes M, Steger CP. Mechanistic aspects of enhanced lipid peroxidation following glutathione depletion in vivo. Chem Biol Interact 1981; 34:257-266.
27. Revesz MEL, Larsson A. Induction and repair of single-strand DNA breaks after X-irradiation of human fibroblasts deficient in glutathione. Int J Radiol Biol 1991; 40:355-363.
28. Skapek SX, Colvin OM, Griffith OW, Groothuis DR, Colapinto EV, Lee Y, Hilton J, Elion GB, Bigner DD, Friedman HS. Buthionine sulfoximine-mediated depletion of glutathione in intracranial human glioma-derived xenografts. Biochem Pharmacol 1988; 37:4313-4317.